eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | multiple endocrine neoplasia type 1 |
| Comorbidity | C0026764|multiple myeloma |
| Sentences | 4 |
| PubMedID- 21482988 | Impact of the conditioning regimen in patients with multiple myeloma who undergo autologous transplantation. |
| PubMedID- 20513117 | A phase ii study of (153)sm-edtmp and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma. |
| PubMedID- 20821326 | Bortezomib-dexamethasone (btz/dex) is an active regimen in patients with multiple myeloma and has been used in few patients with amyloidosis. |
| PubMedID- 20627385 | The efficacy and safety of the low-thalidomide dose ctd (cyclophosphamide, thalidomide, dexamethasone) regimen in patients with multiple myeloma--a report by the polish myeloma study group. |
Page: 1